Pfizer Inc.

A White House plan to offer COVID-19 booster shots will most likely start this month only with the vaccine made by Pfizer Inc and BioNTech, a narrower initiative than anticipated, a source familiar with the matter said.

A White House plan to offer COVID-19 booster shots will most likely start this month only with the vaccine made by Pfizer Inc and BioNTech , a narrower initiative than anticipated, a source familiar with the matter said on Friday.

The U.S government's plan to roll out additional shots of the COVID-19 vaccine for the general public on Sept. 20 will proceed with just the Pfizer/BioNTech SE vaccine, a source familiar with the discussion said on Friday.

Europe's medicines regulator said on Friday it was reviewing if COVID-19 vaccines caused a risk of a rare inflammatory condition, following a report of a case with Pfizer/BioNTech's shot.

Here's what you need to know about the coronavirus right now:

The United States will ship more than 1.2 million doses of COVID-19 vaccines to four African countries through the global COVAX distribution program on Friday, a White House official said.

* EMA: MEETING HIGHLIGHTS FROM THE PHARMACOVIGILANCE RISK ASSESSMENT COMMITTEE (PRAC) 30 AUGUST – 2 SEPTEMBER 2021: 03/09/2021

Australia will receive an additional 4 million doses of Pfizer's COVID-19 vaccine this month after agreeing a swap deal with Britain, to help accelerate its vaccination programme amid a record surge in infections.

Australia will get 4 million doses of the Pfizer Inc coronavirus vaccine in a swap deal with Britain, Prime Minister Scott Morrison said on Friday, days after announcing a smaller swap agreement with Singapore.

Norway will begin to offer COVID-19 vaccines to children aged 12 to 15, Prime Minister Erna Solberg said on Thursday.

The U.S. drug regulator has asked Pfizer, Eli Lilly & Co and AbbVie to include information about the risks of serious conditions and death from the use of their drugs that belong to a class of treatments known as JAK inhibitors.

Moderna Inc on Wednesday asked the U.S. Food and Drug Administration (FDA) to allow the use of a third booster dose of its COVID-19 vaccine.

The U.S. Food and Drug Administration said on Wednesday its outside advisers will meet on Sept. 17 to discuss additional doses of COVID-19 vaccines and specifically Pfizer Inc and partner BioNTech's application for the use of a booster vaccine dose.

The United States has administered a third dose of either Pfizer Inc-BioNTech or Moderna Inc's COVID-19 vaccines to over 1 million people since Aug. 13, when regulators authorized an additional shot for immunocompromised people.

The United States has administered a third dose of either Pfizer Inc or Moderna Inc's COVID-19 vaccines to over 1 million people as of Wednesday morning, the U.S. Centers for Disease Control and Prevention said.

Pfizer Inc and Merck & Co Inc announced on Wednesday new trials of their experimental oral antiviral drugs for COVID-19 as the race to develop an easy-to-administer treatment for the potentially fatal illness heats up.

Britain will give severely immunosuppressed people a third dose of COVID-19 vaccine to increase their chances of generating a better immune response, although officials stressed the offer was separate from any broader booster vaccine programme.

Pfizer Inc said on Wednesday it had started dosing in a mid-to-late-stage trial of its oral antiviral therapy for COVID-19 in non-hospitalized, symptomatic adult patients.

Walmart Inc on Tuesday became the latest U.S. retailer to say that it is ready to administer millions of COVID-19 booster vaccine doses this fall if U.S. health officials endorse such a shot to improve fading immunity against the coronavirus.